Andrew Hill,
Professor and ARC Future Fellow
Andrew Hill is Professor of Biochemistry and Molecular Biology and an Associate Director of the Bio21 Institute at the University of Melbourne. He has studied neurodegenerative diseases for the last 20 years, first undertaking his PhD at Imperial College, London, where he developed a diagnostic and classification system for human prion diseases. In 2000 he moved to the University of Melbourne where established his lab which now studies the molecular and cellular biology of Alzheimer’s, Parkinson’s and prion diseases. Over the last 7 years he has developed an interest in the study of extracellular vesicles and their role in neurodegeneration. Recently, this has led to new studies employing the use of next generation deep sequencing to analyse the RNA content of exosomes in a number of experimental and clinically relevant settings. His work has been published in some of the top scientific journals including Nature, Science, Cell and PNAS and he has been the recipient of several awards and prizes including the 2005 ASBMB Edman Award, a Young Tall Poppy Award in 2006, the ASBMB Merck Research Excellence Medal for 2010. He has published over 120 peer reviewed publications, edited two books, and is on the editorial board of 3 journals. He is currently an Australian Research Council Future Fellow, an honorary National Health and Medical Research Council Senior Research Fellow, and an elected member of the Executive of the International Society of Extracellular Vesicles.
|
|
|
